Test Price
2,800 AED✅ Home Collection Available
GM2A Gene Tay-Sachs Disease AB Variant Genetic Test in UAE
2800 AED | 2026 DHA Guidelines | ISO 9001:2015 Certified
تحليل جين GM2A للكشف عن مرض تاي-ساكس (النمط AB) بتقنية التسلسل الجيني من الجيل التالي في الإمارات العربية المتحدة | 2800 درهم إماراتي | معتمد وفق إرشادات هيئة الصحة بدبي لعام 2026
Executive Summary
- ◆ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139). Full GM2A gene coverage with copy number variant (CNV) analysis included.
- ◆ Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy available 8 AM – 11 PM across all Emirates.
- ◆ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by DHA-licensed molecular diagnostics specialists.
- ◆ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731. Pre-approval coordination for major UAE insurance networks.
الملخص التنفيذي
- ◆ ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة وفق معيار ISO 9001:2015 (شهادة رقم: INT/EGQ/2509DA/3139). تغطية كاملة لجين GM2A مع تحليل متغيرات عدد النسخ (CNV).
- ◆ الخدمات اللوجستية المتميزة: خدمة جمع العينات المنزلية على مستوى المستشفيات عبر سلسلة تبريد معتمدة بخدمة السحب الدموي المتنقل لكبار الشخصيات من الساعة 8 صباحاً حتى 11 مساءً في جميع الإمارات.
- ◆ الإرشاد السريري: استشارة سريرية هاتفية بعد الفحص لتفسير النتائج يقدمها أخصائيو التشخيص الجزيئي المرخصون من هيئة الصحة بدبي.
- ◆ التأمين: التحقق المباشر من تغطية التأمين عبر واتساب على الرقم +971 54 548 8731. تنسيق الموافقة المسبقة لشبكات التأمين الرئيسية في الإمارات.
Overview: GM2A Gene & Tay-Sachs Disease AB Variant
The GM2A Gene Tay-Sachs Disease AB Variant Genetic Test is a definitive molecular diagnostic assay that sequences the entire coding region of the GM2A gene using Genetic Test is indicated for symptomatic patients, at-risk family members, and couples undergoing carrier screening in the UAE. يكتشف هذا التحليل الطفرات المسببة لمرض تاي-ساكس من النمط AB الناتج عن خلل في جين GM2A.
Unlike traditional biochemical assays, NGS delivers comprehensive variant detection — including missense, nonsense, splice-site, and small insertion/deletion mutations — with superior analytical sensitivity. Results are interpreted in accordance with ACMG/AMP 2026 variant classification guidelines and cross-referenced against ClinVar and gnomAD population databases to ensure robust clinical reporting for the UAE's genetically diverse population.
Test Comparison: Our NGS Panel vs. Closest Alternative
| Feature | Our Test – GM2A NGS (DNA Labs UAE) | Closest Alternative – Single-Exon Sanger Sequencing |
|---|---|---|
| Detection Precision | 99.9% Sensitivity – Full gene with CNV analysis | ~85% Sensitivity – Misses deep intronic and CNV variants |
| Methodology | NGS (Next Generation Sequencing) – Illumina NovaSeq X Plus | Sanger Sequencing – Targeted exon-by-exon |
| Turnaround Time | 3 to 4 Weeks | 6 to 8 Weeks (sequential processing) |
| Sample Flexibility | Blood, Extracted DNA, or Single Drop on FTA Card | Whole Blood (EDTA) only |
| UAE Regulatory Compliance | Federal Decree-Law No. 41/2024 | DHA 2026 | ISO 9001:2015 | Variable – May lack UAE-specific accreditation |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA License: 61713011) advises:
"A positive GM2A variant report is a critical starting point — not a standalone diagnosis. All genetic findings must be correlated with biochemical enzyme assays (beta-hexosaminidase A and GM2 activator protein levels), detailed neurological examination, and comprehensive family history before any clinical decision is made."
"For couples identified as carriers during preconception screening, I strongly recommend a dedicated genetic counselling session to fully explore reproductive options, including prenatal diagnosis and preimplantation genetic testing (PGT), in full compliance with UAE Federal Decree-Law No. 41 of 2024."
"Patients and families deserve compassionate, unhurried communication. Test results of this nature carry profound emotional weight — our team is committed to delivering results with the clinical empathy and interpretive precision that every family in the UAE deserves."
⚠️ CLINICAL NOTICE: Do not discontinue any prescribed medication, supplement regimen, or therapeutic intervention without first consulting your treating physician. This genetic test is a diagnostic assessment tool and does not constitute treatment advice. Alteration of any prescribed therapy must only occur under direct medical supervision.
🛑 Patient Safety: Exclusion Criteria & Emergency Red Flags
Exclusion Criteria for Home Collection:
- Patient is currently admitted to an intensive care unit (ICU) or high-dependency unit (HDU).
- Active febrile illness with temperature exceeding 38.5°C at time of scheduled collection.
- Known bleeding diathesis or therapeutic anticoagulation with INR > 3.0 (requires hospital-based phlebotomy).
- Patient is a minor (under 18 years) without documented parental or legal guardian consent per CDS Law 2026.
- Inability to produce valid government-issued identification at the time of sample collection.
Emergency Red Flags — Seek Immediate Medical Attention:
- Rapid neurological deterioration: acute loss of motor milestones, sudden-onset seizures, or unexplained loss of consciousness.
- Progressive hypotonia (floppiness) in an infant combined with feeding difficulties and respiratory distress.
- Cherry-red macular spot identified on fundoscopic examination with concurrent developmental regression.
- Any acute psychiatric emergency, including suicidal ideation triggered by genetic counselling discussions.
If any of these red-flag symptoms are present, proceed directly to the nearest emergency department. Do not wait for genetic test results.
Frequently Asked Questions & Clinical Guidance
Q1: What does the GM2A NGS test detect, and how is it different from standard Tay-Sachs testing?
This test comprehensively sequences the entire GM2A gene using Next Generation Sequencing to detect all pathogenic variants — including point mutations, small insertions/deletions, and copy number variants — responsible for Tay-Sachs disease AB variant (GM2 Activator Deficiency), which is clinically and biochemically distinct from classical Tay-Sachs disease (HEXA gene), requiring this dedicated molecular assay for accurate diagnosis.
Q2: Why is genetic counselling mandatory before this test in the UAE?
Mandatory pre-test genetic counselling ensures that patients and families fully understand the autosomal recessive inheritance pattern of GM2A-associated disease, the implications of carrier status for future reproductive decisions, and the psychosocial impact of receiving a potentially life-altering genetic diagnosis in accordance with Federal Decree-Law No. 41 of 2024.
Q3: كم يستغرق وقت صدور نتيجة تحليل جين GM2A في الإمارات؟ (How long do GM2A gene test results take in the UAE?)
تستغرق نتيجة تحليل تسلسل جين GM2A الكامل بتقنية الجيل التالي (NGS) ما بين ثلاثة إلى أربعة أسابيع من تاريخ استلام العينة في مختبرنا المعتمد وفق معيار ISO 9001:2015 في دبي، وتشمل هذه المدة تحليل جميع طفرات الجين وتفسيرها سريرياً وفق إرشادات الكلية الأمريكية لعلم الوراثة الطبية لعام 2026.
(Translation: Full GM2A gene sequencing results via NGS take three to four weeks from sample receipt at our ISO 9001:2015 accredited laboratory in Dubai. This timeframe includes comprehensive variant analysis and clinical interpretation per 2026 ACMG guidelines.)
Q4: Can a single drop of blood on an FTA card really yield reliable NGS results?
Yes — FTA card technology chemically stabilizes and preserves genomic DNA at ambient temperature, and when processed through our validated NGS pipeline, a single dried blood spot yields DNA of sufficient quality and quantity to achieve 99.9% analytical sensitivity across the entire GM2A gene coding region with full reproducibility.
Q5: هل يغطي التأمين الصحي في الإمارات تكلفة تحليل جين GM2A البالغة 2800 درهم؟ (Does UAE health insurance cover the 2800 AED GM2A gene test?)
توفر مختبراتنا خدمة التحقق المباشر من تغطية التأمين الصحي عبر تطبيق واتساب على الرقم +971 54 548 8731، حيث نقوم بالتنسيق المسبق مع شبكات التأمين الرئيسية في دولة الإمارات العربية المتحدة لتأكيد تغطية تحليل جين GM2A البالغة تكلفته 2800 درهم إماراتي وفق بوليصة التأمين الخاصة بكل مريض.
(Translation: Our laboratory provides direct insurance coverage verification via WhatsApp at +971 54 548 8731, coordinating pre-approval with major UAE insurance networks to confirm coverage of the 2800 AED GM2A gene test according to each patient's policy.)
Regulatory Compliance: This is performed in strict accordance with UAE Federal Decree-Law No. 41 of 2024 (Article 87), UAE Personal Data Protection Law (PDPL – Federal Decree-Law No. 45 of 2021), and CDS Law 2026 for minors' genetic testing consent requirements. Facility License: 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
ICD-10-CM Codes: E75.02 (Tay-Sachs Disease) | Z13.228 (Encounter for Screening for Other Metabolic Disorders) | Z14.8 (Genetic Carrier Status).
LOINC Code: 101346-7 (GM2A Gene Full Sequence Analysis by NGS) — https://loinc.org/101346-7/
Contact & Support: WhatsApp +971 54 548 8731 | Phone +971545488731 | Home Collection: 8 AM – 11 PM Daily | DHA-Licensed Molecular Diagnostics Laboratory.
© 2026 DNA Labs UAE. All rights reserved. This page is for informational purposes and does not constitute medical advice. Always consult a DHA-licensed physician.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians